# FDA Inspection 854891 - Hillcrest Medical Center Blood Bank - October 31, 2013

Source: https://www.keypedia.com/records/fda_inspections/hillcrest-medical-center-blood-bank/e185d7d6-4239-45af-8016-8fca4c0af034
Source feed: FDA_Inspections

> FDA Inspection 854891 for Hillcrest Medical Center Blood Bank on October 31, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 854891
- Company Name: Hillcrest Medical Center Blood Bank
- Inspection Date: 2013-10-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 963555 - 2016-03-09](https://www.keypedia.com/records/fda_inspections/hillcrest-medical-center-blood-bank/4a71e6c3-5b40-44e0-8c92-4d490003c4ce)
- [FDA Inspection 750106 - 2011-10-19](https://www.keypedia.com/records/fda_inspections/hillcrest-medical-center-blood-bank/0d18ecf8-dcd7-457a-ac6a-202589dbbf38)
- [FDA Inspection 634476 - 2009-12-03](https://www.keypedia.com/records/fda_inspections/hillcrest-medical-center-blood-bank/ed3ebc92-4dc8-47f9-bcf6-c6762da86f83)

Company: https://www.keypedia.com/companies/hillcrest-medical-center-blood-bank/e98aa5d2-8e91-4938-9d6c-3131759d0551

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d